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The molecular nature of calcium (Ca
2þ)-dependent mechanisms and the ion channels having a major role in the apoptosis of
cancer cells remain a subject of debate. Here, we show that the recently identiﬁed Orai1 protein represents the major molecular
component of endogenous store-operated Ca
2þ entry (SOCE) in human prostate cancer (PCa) cells, and constitutes the
principal source of Ca
2þ inﬂux used by the cell to trigger apoptosis. The downregulation of Orai1, and consequently SOCE,
protects the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumor necrosis
factor a, and cisplatin/oxaliplatin. The transfection of functional Orai1 mutants, such as R91W, a selectivity mutant, and L273S, a
coiled-coil mutant, into the cells signiﬁcantly decreased both SOCE and the rate of Tg-induced apoptosis. This suggests that
the functional coupling of STIM1to Orai1,as well asOrai1 Ca
2þ-selectivity asa channel, is required for its pro-apoptotic effects.
We have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of
Orai1 expression as well as SOCE. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-
operated channel current and restored the normal rate of apoptosis. Thus, Orai1 has a pivotal role in the triggering of apoptosis,
irrespective of apoptosis-inducing stimuli, and in the establishment of an apoptosis-resistant phenotype in PCa cells.
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Early and pivotal events in apoptosis are now known to occur
in mitochondria and the endoplasmic reticulum (ER), where
the release of cytochrome c from the mitochondria and
calcium (Ca
2þ) from the ER into the cytosol is a requisite for
apoptosis in many cases.
1 Irrespective of apoptosis-induced
stimuli, a lethal inﬂux of Ca
2þ constitutes a sine qua non
condition of apoptosis. The recruitment of three major Ca
2þ-
dependent apoptotic mechanisms, mitochondrial, cyto-
plasmic and ER, were already shown (for reviews, see
Prevarskaya et al.,
2 Pinton et al.
3 and Norberg et al.
4).
However, until now, the speciﬁc mechanisms through which
Ca
2þ dynamics are controlled and by which Ca
2þ partici-
pates in apoptotic cascades have been elusive. The function
of Ca
2þ in apoptosis is particularly fascinating, especially
when we consider the prominence of Ca
2þ in regulating a
multitude of physiological processes and the involvement of
perturbed cellular Ca
2þ homeostasis in the pathogenesis.
Prostate cancer (PCa) is the second most lethal tumor
among men, wherein the major hallmark is the acquired
resistance to apoptosis rather than enhanced proliferation.
5,6
The early stage of PCa depends on the androgens needed for
growth and survival, and androgen ablation therapy may at
this time be effective in causing the tumor to regress due to
the induction of massive apoptosis.
7 Unfortunately, PCa
progresses into an androgen-independent stage, causing
cancer relapse with the appearance of more aggressive cell
phenotypes characterized by enhanced apoptosis resistance.
Despiteagrowingnumberofstudies,themechanismsleading
to these phenotypes are still poorly deﬁned, even though
understanding the factors that drive PCa to apoptosis
resistance is vital for the development of new therapies for
advanced PCa.
A number of studies have shown that a large, sustained
inﬂux of Ca
2þ triggering apoptosis in cancer cells is provided
by capacitative or store-operated Ca
2þ entry (capacitative
calcium entry (CCE) or store-operated calcium entry
(SOCE)), mediated by store-operated channels (SOCs).
8,9
SOCs are located in the plasma membrane (PM) and are
activated by store depletion in the ER. Ca
2þ entry via SOCs
induces a sustained increase in the cytosolic Ca
2þ concen-
tration, thus restoring the ER Ca
2þ content. Therefore,
when SOCs are activated, they regulate both cytosolic and
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2þ concentrations. This is one reason why
SOCs have become of great interest as potential apoptosis
regulators.
8 Moreover, we have previously shown that the
inhibition of apoptosis in androgen-independent PCa cells
was associated with the downregulation of SOCs due to a
decrease in the number of functional channels.
9 Never-
theless, despite considerable progress in the understanding
ofSOCs,themolecularnatureofthechannelsinvolvedinPCa
cell apoptosis, and thus contributing to the development of
apoptosis resistance, remains unknown.
Our work here focused on studying the molecular mechan-
isms involved in the enhanced apoptosis resistance of PCa
cells in their transition to the most aggressive hormone-
refractory stage.
Results
Orai1 and STIM1 expression and their involvement in
CCE in steroid-deprived PCa cells. The whole-cell
conﬁguration of the patch-clamp technique was used to
compare the amplitudes of SOC current (ISOC) in lymph node
carcinoma of the prostate cells (LNCaP) and steroid-
deprived LNCaP (LNCaP-ST) cells. As documented in
Figure 1a–c, ISOC induced by the cell dialysis, with the
basic intracellular solution supplemented with either IP3
(100mM) or EGTA (5mM) (EGTAþBAPTA), was approxi-
mately 50% lower in LNCaP-ST cells compared with the
regular LNCaP cells. This correlated nicely with the decrease
in Orai1 expression in LNCaP-ST cells (Figure 1d) as
assayed by the quantitative PCR and western blotting
(Figure 1f). As Orai1 is known to colocalize with the ER
Ca
2þ sensor, STIM1, at ER–PM junctions and requires
STIM1 translocation into punctate structures to be
activated,
10 we also checked for STIM1 expression during
steroid deprivation. In contrast to Orai1, the expression of
STIM1 remained invariable irrespective of whether or not
androgens were present in the culture medium (Figure 1d).
TodemonstratetheinvolvementofSTIM1andOrai1inISOC
in LNCaP cells, we conducted a series of siRNA-mediated
knockdown experiments. As shown in Figure 1e–h, a 24-h
treatment with siRNA against Orai1 (si-Orai1) signiﬁcantly
reduced Orai1 mRNA (Figure 1g) and protein (Figure 2e) in
LNCaP cells. This was paralleled by a decrease in the IP3-a s
well as EGTAþBAPTA-evoked ISOC density by 75.4±7.5%
and 77.8±11.3%, respectively (Figure 1e). Similarly, the
use of siRNA against STIM1 (si-STIM1) speciﬁcally dec-
reased STIM1 protein expression by approximately 80%
(Figure 1i) and correlated with a reduction in both IP3- and
EGTAþBAPTA-induced ISOC density by 80.5±8.4% and
83.5±4.2%, respectively (Figure 1h).
Downregulation of Orai1 confers apoptosis resistance to
LNCaP cells. In view of the major role of Orai1 in PCa cells’
SOCE and the decrease in Orai1 expression following
androgen withdrawal, we next sought to examine Orai1
involvement in apoptosis. The classic apoptosis inducer,
thapsigargin (Tg, a SERCA pump inhibitor that triggers
Ca
2þ-dependent apoptosis via ER Ca
2þ store depletion and
SOCE (e.g., Prevarskaya et al.
2)) was used.
WeusedtheTUNELtechnique(includingbothnegativeand
positive controls) to measure the apoptosis rate of LNCaP
cells (Figure 2a). Cells were transfected with either si-Orai1 or
si-Ctrl and the day after treated with 1mM TG for 24h. As
revealed by TUNEL staining, a 24-h Tg treatment is sufﬁcient
toinduceapoptosisinaround50%ofLNCaPcells(Figure2b).
However, knocking down Orai1 expression (with si-Orai1,
Figure 2e) made the cells much more resistant to Tg-induced
apoptosis (4.24±1.47 versus 48.4±4.9%; Figure 2b). This
result was conﬁrmed by Hoechst nuclear staining, which
revealed 27% of apoptosis in control cells after a 24-h Tg
treatment and approximately 8% in si-Orai1-transfected cells
(Figure 2c). Thus, Orai1 appears to be an important player
in Tg-induced apoptosis, most likely as the key provider of
lethal Ca
2þ inﬂux in response to Tg-induced ER Ca
2þ store
depletion and consecutive SOCE. To validate the role
of Orai1 in response to physiological pro-apoptotic signals,
weconductedsimilarexperimentswithtumornecrosisfactora
(TNFa). TNFa 10ng treatment for 48 h triggered apoptosis in
7.25% of the control LNCaP cells, and in only 2.5% of the
Orai1-knockdown LNCaP cells (Figure 2d).
To assess whether Orai1 underexpression could be
involved in resistance to chemotherapy-induced apoptosis,
we also investigated the cisplatin- and oxaliplatin-evoked
apoptosis.Theuseof20mMcisplatin(Y)and40mMoxaliplatin
(X),twoverystrongalkylatingagents,resultedinanapoptosis
rate that was signiﬁcantly diminished in the Orai1-knockdown
LNCaP cells (Figure 3a). Even in the case of these strong
alkylating agents si-Orai1 was able to protect the cells against
apoptosis (Figure 3b). Moreover, a 24-h pretreatment with
either 20mM cisplatin or 40mM oxaliplatin showed a statisti-
cally signiﬁcant increase in basal Ca
2þ level as compared
with control DMSO-treated cells (data not shown). These
data provide the evidence of the possible link between the
alkylating agent and Ca
2þ-homeostasis. Thus, our data
suggest that Orai1 underexpression might prevent apoptosis
triggeredeitherphysiologicallyorbychemotherapiesandthus
might be important in PCa progression.
Loss of Orai1 function protects LNCaP cells against
Tg-induced apoptosis. To further study the role of Orai1
in apoptosis, we used two functional Orai1 mutants
described as ISOC inhibitors: the ‘selectivity mutant’ R91W,
which prevents Ca
2þ permeation through Orai1,
11 and the
‘coiled-coiled mutant’ L273S, which impairs the interaction
between STIM1 and Orai1 and thus inhibits its activation.
12
Electrophysiological measurements on LNCaP cells
transiently transfected with the YFP-tagged R91W mutant
(YFP-Orai1-R91W) or YFP-tagged L273S mutant (YFP-
Orai1-L273S) (Figure 4a) revealed a signiﬁcantly reduced
IP3- and EGTAþBAPTA-evoked ISOC density compared with
the control LNCaP cells, consistent with the negative action
of these mutants on endogenous Orai1 function.
Moreover, similar to what has been observed with an
siRNA-mediated Orai1 knockout, LNCaP cells transfected
withanyoftheOrai1mutantsshowedanenhancedresistance
to Tg-induced apoptosis. A 24-h exposure to Tg caused
22±4% of apoptosis in the control LNCaP cells, and in the
cells transfected with YFP-Orai1-R91W or YFP-Orai1-L273S,
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Cell Death and Diseasethe apoptosis rate was decreased by approximately 70–80%
(6±3% and 5±2%, respectively; Figure 4b).
Taken together, these data indicate that Orai1 forms
a major Ca
2þ entry pathway required in Ca
2þ-induced
apoptosis: the downregulation or the loss of Orai1 function
triggers apoptosis resistance. On the other hand, the Orai1
gain of function by co-expressing both CFP-tagged Orai1
and YFP-tagged STIM1 in LNCaP cells produced a 10-fold
Figure1 TheexpressionofOrai1andSTIM1insteroid-deprivedprostatecancerepithelialcellsandtheirinvolvementinSOCE.(a,b)RepresentativetimecoursesofISOC
development (measured at  100mV holding potential) in control LNCaP (black circles) and LNCaP-ST (white squares) cells in response to the dialysis of 100mMI P 3
(a)o r5m ME G T A( b). (c) Quantiﬁcation of IP3- and EGTAþBAPTA-induced ISOC densities in control LNCaP (black columns, 2.25±0.23pA/pF, n¼23 and 0.73±0.18pA/pF,
n¼31,respectively)andinLNCaP-ST(whitecolumns,0.96±0.32pA/pF,n¼17 and0.42±0.12pA/pF,n¼21,respectively)cells.(d)Real-timequantitativePCRshowing
the expression of Orai1 and STIM1 in control LNCaP cells (CT) and LNCaP cells cultured for 3 days in steroid-deprived medium (3 days). (e) Quantiﬁcation of IP3- and
EGTAþBAPTA-induced ISOC densities in LNCaP following 24h of transfection with control siRNA (si-Ctrl, white columns, 1.78±0.18pA/pF, n¼23 and 0.56±0.13pA/pF,
n¼22,respectively)andanti-Orai1siRNA(si-Orai1,blackcolumns,0.44±0.13pA/pF,n¼19and0.12±0.06pA/pF,n¼22,respectively).(f)Awesternblottingexperiment
showingtherelativeexpressionofOrai1proteinuponandrogenwithdrawalinLNCaPcells.Thedataarenormalizedtotheexpressionofb-actin.(g)RepresentativeRT-PCRs
showing the dynamics of Orai1 mRNA expression in LNCaP cells following 24, 48, or 72h of transfection with anti-Orai1 siRNA (si-Orai1); CT stands for the cells transfected
with control si-RNA; the numbers represent the relative amounts of Orai1 mRNA compared with b-actin mRNA. (h) Quantiﬁcation of IP3- and EGTAþBAPTA-induced ISOC
densities in LNCaP following 24h of transfection with control siRNA (si-Ctrl, white columns, 2.52±0.28pA/pF, n¼18 and 0.70±0.05pA/pF, n¼24, respectively) and
anti-STIM1siRNA(si-STIM1,blackcolumns,0.49±0.23pA/pF,n¼18and0.11±0.03pA/pF,n¼23,respectively).(i)Representativewesternblotshowingthedynamicsof
the hSTIM1 protein (77kDa) expression in LNCaP cells following 24, 48 or 72h of transfection with anti-hSTIM1 siRNA (si-STIM1); CT stands for the cells transfected with
control si-RNA; numbers represent relative amounts of hSTIM1 protein compared with b-actin protein (42kDa). Throughout the ﬁgure, (*) and (**) denote statistically
signiﬁcant differences with Po0.05 and Po0.02, respectively
Orai1 in apoptosis resistance of prostate cancer
M Flourakis et al
3
Cell Death and Diseaseincrease in the ISOC density in response to the infusion of
either IP3 or EGTAþBAPTA compared with the respective
controls (Figure 4c). At the same time, the co-expression of
Orai1 and STIM1 more than doubled the Tg-induced
apoptosis (50±6% versus 22±4% apoptosis rate;
Figure 4d). The control of CFP-tagged Orai1 and YFP-tagged
STIM1 transfections into LNCaP cells was performed using
confocal microscopy (Figure 4e). Thus, the ampliﬁcation of
SOCE due to Orai1 and STIM1 overexpression correlates
with the marked increase in Tg-induced apoptosis.
Orai1 rescue restores Ca
2þ-induced apoptosis in LNCaP-ST
cells: a possible regulation by androgens. We have
shown that the decrease in Orai1 expression and the
density of ISOC were responsible for the apoptosis
resistance of androgen-deprived LNCaP-ST cells. To
further demonstrate the role of Orai1 in apoptosis, we
rescued Orai1 expression in LNCaP-ST cells. The cells
were transfected with CFP-tagged Orai1. Orai1
overexpression in LNCaP-ST cells resulted in an
approximate twofold increase of both IP3- and
EGTAþBAPTA-activated ISOC densities compared with the
respective controls (Figure 5a), indicating that Orai1
overexpression was able, at least in part, to rescue SOCs
downregulated by androgen deprivation. This rescue
essentially restored the rate of Tg-induced apoptosis
Figure 2 Underexpression of Orai1 protects LNCaP cells against apoptosis. (a) Apoptotic cells revealed using TUNEL technique. (b) Quantiﬁcation using TUNEL of the
apoptosis rate (Ctrl, DMSO-treated, gray columns) and apoptosis induced by Tg (1mM, 24h, black columns) in control LNCaP cells (si-Ctrl) and LNCaP cells with si-RNA-
mediated Orai1 silencing (si-Orai1). (c) Quantiﬁcation using Hoechst technique of the apoptosis rate (Ctrl, DMSO-treated, gray columns) and apoptosis induced by Tg (1mM,
24h, black columns) in control LNCaP cells (si-Ctrl) and LNCaP cells with si-RNA-mediated Orai1 silencing (si-Orai1). (d) Apoptosis induced by TNF-a (10ng/ml, 48h, black
columns) in control LNCaP cells (si-Ctrl) and LNCaP cells with si-RNA-mediated Orai1 silencing (si-Orai1) (quantiﬁed using Hoechst technique). (e) A representative western
blotting of si-Orai1 knockdown in LNCaP cells. The data are normalized to the expression of b-actin. Throughout the ﬁgure, (*) and (***) denote statistically signiﬁcant
differences with Po0.05 and Po0.01, respectively
Orai1 in apoptosis resistance of prostate cancer
M Flourakis et al
4
Cell Death and Diseaseof Orai1-overexpressing cells (from 9±4% to 16±6%),
bringing it closer to the value of normal LNCaP cells
(24±7%, Figure 5b).
To establish the link between Orai1 and the androgen-
independent PCa phenotype, we sought to examine whether
the androgen receptor (AR) could regulate Orai1 expression.
To directly demonstrate that the orai1 gene is dependent on
the functional AR, we used siRNA against AR (si-AR). As
shown in Figure 5d, after 48h of siAR transfection, the mRNA
level of Orai1 was decreased by 70% in the LNCaP cells.
Patch-clamp experiments using siAR-transfected cells
revealed that their IP3- and EGTAþBAPTA-evoked ISOC
were also reduced by 63% and 67%, respectively (Figure 5c).
This result indicates that the AR could regulate Orai1
expression. To further study this potential regulation, we have
also used the MatInspector 7.7.3 program (Genomatix Soft-
ware GmbH, Munich, Germany) to analyze the putative AR
binding sites on Orai1 promoter (see the appropriate section
of the discussion).
Discussion
The appearance of apoptotic resistance in cancer cells is a
crucial step for the development and progression of human
PCatothehormone-refractoryandrogen-independentpheno-
type. In the present study, we report three major ﬁndings that
will allow the understanding of the mechanisms for the
acquisition of apoptosis resistance by PCa cells: (i) the
decrease of the endogenous ISOC is a characteristic feature of
the androgen-independent phenotype, caused by the down-
regulation of the Orai1 channel; (ii) the downregulation of both
Orai1 expression and ISOC is used by the PCa cells to develop
the apoptosis resistance crucial for PCa development and its
progression to the hormone-refractory stage; (iii) Orai1 is a
commonlink betweenCa
2þ andapoptosis,irrespective ofthe
nature of the apoptosis-triggering stimuli.
The involvement of Ca
2þ-dependent mechanisms in the
induction and regulation of apoptosis is now well established.
Figure 3 The role of Orai1 in apoptosis induced by alkylating agents cisplatin
and oxaliplatin. (a) Representative images of apoptosis rate measured using the
Hoechst technique of LNCaP cells treated with 20mM cisplatin. White arrows
indicate the apoptotic nuclei. (b) A corresponding histogram showing the apoptosis
of LNCaP cells treated with either 20mM cisplatin (Y) or 40mM oxaliplatin (X) in
siCT- and siOrai1-pretreated cells. (*) denotes statistically signiﬁcant differences
with Po0.05 (quantiﬁed using the Hoechst technique)
Figure 4 Loss of Orai1 function protects LNCaP cells against thapsigargin
(Tg)-inducedapoptosis.(a)QuantiﬁcationofIP3-andEGTAþBAPTA-inducedISOC
densities in control LNCaP cells (pcDNA3, black columns, 1.8±0.15pA/pF, n¼18
and 0.8±0.15pA/pF, n¼14, respectively) and LNCaP cells transfected with YFP-
Orai1L273S(darkgraycolumns,0.41±0.18pA/pF,n¼18and0.34±0.12pA/pF,
n¼16,respectively)orYFP-Orai1R91W(graycolumns,0.46±0.12pA/pF,n¼18
and 0.25±0.08pA/pF, n¼16, respectively). (b) Quantiﬁcation of the baseline
apoptosis (pcDNA3, DMSO-treated, gray columns) and apoptosis induced by
Tg (1mM, 24h, black columns) in control LNCaP cells (Ctrl) and LNCaP cells
transfected with Orai1-L273S or Orai1-R91W mutants (quantiﬁed using Hoechst
technique). (c) Quantiﬁcation of IP3- and EGTAþBAPTA-induced ISOC densities
in control LNCaP cells (Ctrl, gray columns, 2.1±0.18pA/pF, n¼19 and
19±2.8pA/pF, n¼32, respectively) and LNCaP cells co-transfected with YFP-
STIM1 and CFP-Orai1 (black columns, 0.75±0.12pA/pF, n¼16 and
3.1±0.75pA/pF, n¼33, respectively). (d) Quantiﬁcation of the baseline
apoptosis (pcDNA3, DMSO-treated, gray columns) and apoptosis induced by Tg
(1mM, 24h, black columns) in control LNCaP cells (pcDNA3) and LNCaP cells
co-transfected with YFP-STIM1 and CFP-Orai1 (quantiﬁed using Hoechst
technique). (e) Representative images of LNCaP cell co-transfected with YFP-
STIM1 (left) and CFP-Orai1 (middle) and their overlay (right). A white bar in the left
panel represents 5mm distance. Throughout the ﬁgure, (*) and (**) denote
statistically signiﬁcant differences with Po0.05 and Po0.01, respectively
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Cell Death and DiseaseAlterations in the ER storage capacity and SOC activity seem
to have a major role in the establishment of an androgen-
independent apoptosis-resistant phenotype of PCa cells.
Indeed, as we have shown in our previous works on
androgen-independent, apoptosis-resistant phenotypes of
LNCaP PCa cells (such as androgen-deprived LNCaP cells,
LNCaP cells overexpressing the anti-apoptotic Bcl-2 protein
and neuroendocrine-differentiated LNCaP cells), increased
resistance to Tg- and TNF-a-induced apoptosis is character-
ized by (i) the reduced basal Ca
2þ ﬁlling of the ER pool and
(ii) reduced store-operated Ca
2þ entry.
5,13 The primary
trigger for apoptosis in androgen-dependent cells is ER store
depletion and a sustained Ca
2þ inﬂux may not even be
required.
8 Interestingly, for androgen-independent cells, ER
store depletion per se is not sufﬁcient to induce cell death
without the lethal Ca
2þ inﬂux from SOCE.
2,9,14 Therefore, the
identiﬁcation of the molecular nature of SOC and their
activation/regulation mechanisms are of great importance
for controlling androgen-independent PCa cell apoptosis.
During recent years, a new molecular candidate for SOC
termed Orai1 has been identiﬁed and characterized. Orai1
mediates CRAC currents and SOCE in a large variety of cells
and is involved in a wide range of cell functions, including
endothelial cell proliferation,
15 lymphocyte proliferation,
16
mast cell activation,
13 as well as skeletal muscle development
and a contractile function.
17 However, despite the suggested
pivotal role of SOCs in the apoptosis resistance of PCa cells,
the involvement of Orai1 in prostate-speciﬁc SOC, as well as
in Ca
2þ-dependent apoptosis of PCa cells, has never been
studied.
In the present study, we have shown that Orai1, an ion
channelinthePM,andSTIM1,asasignaltransducerfromthe
ER, represent the major molecular components of SOCE in
PCa epithelial cells: the siRNA-mediated knockout of any of
them strongly diminishes ISOC in LNCaP cells. However, as
only Orai1 expression was found to decrease in LNCaP
cells following androgen deprivation, we hypothesized that
the downregulation of ISOC, which follows the transition of
PCa cells to androgen independence and apoptosis resis-
tance, is associated, at least in part, with the reduction of
Orai1 levels.
Androgen ablation therapy in prostate adenocarcinoma
induces an involution of prostate tissue mainly through the
enhancement of cellular apoptosis.
18 However, a subset of
malignant cells emerges as a new population of apoptosis-
resistant cells. The enrichment of the prostate with such cell
phenotypes eventually causes virtually all tumors to relapse
into an androgen-independent, more aggressively growing
type.
18
Androgens have an essential role in prostate carcinogen-
esis and androgen independency of the most malignant
androgen-independent phenotype, which is known to arise
fromlossoftheAR(e.g.,Bonkhoff
19).Therefore,weassumed
that the decrease in Orai1 expression and ISOC density
following the induction of LNCaP cell differentiation by
androgen withdrawal occurs because orai1 gene expression
mightberegulatedbythefunctionalAR.Ourdatashowedthat
AR silencing in LNCaP cells leads to a dramatic decrease in
Orai1 expression as well as in ISOC density. The structure of
the promoter of such a classic androgen-dependent gene as
the prostate-speciﬁc antigen usually includes an androgen-
responsive element (ARE) close to the transcriptional start
site and other AREs located several kilobase pairs upstream
within the enhancers.
20 In order to estimate a possible orai1
gene regulation by AR, we studied the human Orai1 promoter
sequence. The genomic sequence corresponding to 6200bp
upstream and 100bp downstream of hOrai1 ATG was used
for the transcription factor analysis. The MatInspector 7.7.3
program was used to analyze the putative AR binding sites.
21
The orai1 promoter sequence was analyzed for the presence
of AREs using a prostate-speciﬁc matrix, which is associated
with transcription factors that are expressed and transcrip-
tionally active in this tissue. We identiﬁed several AREs: three
of them located at  3700,  4105 and  4700bp from the
Orai1 ATG codon with more than 80% of matrix similarity.
These results may suggest that Orai1 is probably an
androgen-responsive gene in the prostate. Moreover, given
that Orai1 represents a key component of prostate-speciﬁc
SOC, we hypothesized that the decrease of functional SOCs
during PCa progression to the aggressive androgen-indepen-
dent stage results from downregulation of the functional AR
and ultimately the deregulation of Orai1.
The transition to the androgen-independent phenotype not
only inﬂuences Orai1 expression and the SOCE, but, more
importantly, the acquisition of apoptosis resistance also.
Figure 5 Rescueof Orai1inandrogen-deprived prostatecancercells abolishes
apoptosis resistance. (a) Quantiﬁcation of IP3- and EGTAþBAPTA-induced ISOC
densities in control LNCaP-ST cells (pcDNA3, gray columns, 0.89±0.13pA/pF,
n¼13 and 0.33±0.11pA/pF, n¼14, respectively) and LNCaP-ST cells
transfected with CFP-Orai1 (black columns, 2.1±0.18pA/pF, n¼21 and
0.75±0.12pA/pF, n¼23, respectively). (b) Quantiﬁcation of the baseline
apoptosis (pcDNA3, DMSO-treated, gray columns) and apoptosis induced by Tg
(1mM, 24h, black columns) in control LNCaP cells and in LNCaP-ST cells with or
without Orai1 rescued by transfection with CFP-Orai1 (quantiﬁed using the Hoechst
technique). (c) Quantiﬁcation of IP3- and EGTAþBAPTA-induced ISOC densities in
LNCaP following 48h of transfection with control siRNA (si-Ctrl, white columns,
2.01±0.19pA/pF, n¼19 and 0.78±0.25pA/pF, n¼18, respectively) and anti-
ARsiRNA(si-AR,blackcolumns,0.81±0.14pA/pF,n¼21and0.32±0.10pA/pF,
n¼15, respectively). (d) Representative RT-PCRs showing changes in Orai1
and androgen receptor (AR) mRNA expression in LNCaP cells following 48h of
transfection with anti-AR siRNA (si-AR) compared with the cells transfected with
control si-RNA (CT); numbers represent relative amounts of Orai1 and AR mRNA
comparedwith b-actinmRNA.Throughouttheﬁgure,(*) and(**) denotestatistically
signiﬁcant differences with Po0.05 and Po0.02, respectively
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Cell Death and DiseaseWe have found that susceptibility of the cells to the induction
ofCa
2þ-dependentapoptosiswasalwaysindirectcorrelation
with Orai1 expression and ISOC density: the lower the current
density (i.e., low Orai1 expression), the higher the apoptosis
resistance is (i.e., low apoptosis rate). This correlation existed
independently of the experimental tools used to reduce Orai1
expression and activity: the androgen-dependence status of
the LNCaP cells (i.e., androgen deprivation or AR silencing),
the targeted downregulation of Orai1 (anti-Orai1 siRNA) or
Orai1mutants.Interestingly,thepro-apoptoticeffectsofOrai1
were independent of the apoptosis-inducing stimuli. Orai1
downregulation is likely to diminish the sustained cytosolic
Ca
2þ increase and protect PCa cells from apoptosis. We ﬁrst
usedaclassicalCa
2þ-dependentapoptosisinducer,Tg.Tgis
a very powerful tool and as such was even recently proposed
to be used as a ‘smart bomb’ to target androgen-independent
PCa.
22 Our data demonstrate that Tg-evoked apoptosis was
predominantly mediated via Orai1 activation and the efﬁcient
knockdown of the latter may be an important means to protect
the cell from eventual death. To distinguish between
direct and indirect Ca
2þ-dependent apoptosis, we used
another apoptosis inducer, TNFa, a pro-inﬂammatory cyto-
kine that deregulates Ca
2þ homeostasis by inducing ER
stress. According to our previous observations, TNFa is an
effective pro-apoptotic agent of PCa epithelial cells.
9 Indeed,
TNFa induced apoptosis of the LNCaP cells; however, even
this non-direct Ca
2þ-dependent mechanism was signiﬁcantly
blocked by the Orai1 knockdown, suggesting that Orai1-
mediated Ca
2þ entry has a major role in apoptosis, especially
in its early phase. Furthermore, we used two other strong
apoptosis inducers: cisplatin and oxaliplatin. These alkylating
agents react in vivo by binding to and causing crosslinking of
DNA, which ultimately triggers apoptosis (for a review, see
Gonzalez et al.
23). Cisplatin-induced DNA damage seems to
be a long and complex process of cell death and because
cisplatinisanonspeciﬁcdrugthatreactsnotonlywithDNAbut
also with proteins, there is a possibility that an easier process
of initiation, such as damage to cytoplasmic proteins, may
take place.
23 Moreover, inhibition of the proteasome induces
ER stress and also activates the unfolded protein response,
thereby triggering apoptosis.
24 Cisplatin has also been shown
to stimulate ER stress and increase ER dilation, intracellular
Ca
2þ levels, and cell death.
25 This eventually links cisplatin
with ER stress and increased intracellular Ca
2þ levels, which
may be successfully inhibited by Orai1 knockdown with the
consecutive downregulation of ISOC and apoptosis in general.
In fact, we have previously shown that ER stress induces
Ca
2þ entry,
26 and we observed that 24-h pretreatment with
either cisplatin or oxaliplatin increases the cytoplasmic
[Ca
2þ].
Finally, recent studies, concerning Orai1 activation, have
shown that the overexpression of both Orai1 and STIM1
induces a 20-fold increase in the ISOC, resulting in a ‘monster
CRAC’.
27 The gain of SOC function in the androgen-
dependent LNCaP cells in response to the overexpression
of Orai1 and STIM1 was manifested by the appearance of a
high-amplitude ISOC, which led to the marked enhancement of
Ca
2þ-dependent apoptosis. Moreover, the rescue of the ISOC
function by Orai1 overexpression in androgen-deprived
apoptosis-resistant LNCaP cells is able to restore the
apoptosis rate close to that of androgen-dependent PCa
cells. This result is especially impressive, as it is relevant to
the development of perspective therapies for advanced,
androgen-independent PCas.
Thus, we have shown the involvement of Orai1 as a
principal molecular component of native SOCs in the
Ca
2þ-dependent apoptosis of PCa cells. Our results con-
clude that the transition to the androgen-independent PCa
phenotype is associated with the loss of Orai1 expression
leading to the downregulation of SOCE, which precludes
cytosolic Ca
2þ increases that are sufﬁcient enough to induce
apoptosis via well-known mitochondrial and cytosolic
mechanisms. In addition, reduced SOCE may contribute to
the chronic underﬁlling of ER Ca
2þ stores, which represent
the new state of equilibrium for androgen-independent PCa
cells,
2 further enhancing their apoptosis resistance (Figure 6).
Our data are consistent with the notion that SOCE and
Orai1 are important players in apoptosis induction. However,
it seems that apoptosis is not the only process directly related
to SOCE. A recent study revealed that Orai1/STIM1 and
SOCE are also essential for breast tumor cell migration,
invasion and metastasis.
28 It also has been shown that the
SOCE and STIM1/Orai1 are involved in migration, prolifera-
tion,
29 and cell cycle progression.
30 Thus, Orai1/STIM1 and
SOCE seem to have important roles in the wide spectrum of
Ca
2þ-dependent cancer-related behaviors, and are expected
to have a signiﬁcant impact on future research.
Materials and Methods
Cell culture. The androgen-dependent human PCa cell line LNCaP was
obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA)
and maintained in culture in RPMI 1640 medium (Gibco-Life Technologies,
Carlsbad, CA, USA) supplementedwith 10% fetal calf serum (Seromed, Poly-Labo,
Strasbourg, France), 5mM L-glutamine (Sigma, L’Isle d’Abeau, France), and
kanamycin 100mg/ml. Charcoal-striped fetal calf serum (10%) was addedto phenol
red-free RPMI medium together with kanamycin and L-glutamine (as above) to
Figure 6 Schematic diagram summarizing the principal ﬁndings of this study.
The progression to androgen-independent PCa is associated with the appearance
of new cell phenotypes characterized by decreased SOCE due to the
downregulation of Orai1, which results in enhanced resistance to Ca
2þ-dependent
apoptosis. This natural process, which occurred in the in vivo tumors, can be
mimicked by the artiﬁcial silencing of Orai1 expression or inhibition of Orai1 function
with dominant-negative mutants. On the other hand, rescuing Orai1 in androgen-
independent PCa cell phenotypes can restore the normal rate of Ca
2þ-dependent
apoptosis, thus providing the means for the perspective therapies of advanced PCa
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Cell Death and Diseasecreate steroid-deprived conditions. Cells were grown at 371C in a humidiﬁed
atmosphere containing 5% CO2. The medium was replaced every 48h. For the
experiments, cells were seeded in six-well plates for PCR and western blotting,
35-mm culture for the patch-clamp experiments, and onto glass coverslips for the
confocal microscopy.
Electrophysiology and solutions. Macroscopic currents were recorded
fromLNCaPcells inthewhole-cellconﬁguration ofthepatch-clamptechniqueusing
a computer-controlled EPC-9 ampliﬁer (HEKA Electronic, Lambrecht/Pfalz,
Germany), as previously described.
26
The composition of the extracellular solution for patch-clamp recording was
(in mM): 120 NaCl, 5 KCl, 10 CaCl2, 2 MgCl2, 5 glucose, and 10 HEPES, pH 7.4
(adjusted with TEA-OH), osmolarity 310mOsm/kg adjusted with D-mannitol. The
patch pipettes were ﬁlled with the basic intracellular pipette solution (in mM): 120
Cs-methane sulfonate, 10 CsCl, 10 HEPES, 10 BAPTA (1.2-bis(2-aminophen-
oxy)ethaneN,N,N 0,N 0-tetraaceticacid),and6MgCl2(pHadjustedto7.4withCsOH
and osmolarity 295mOsm/kg adjusted with D-mannitol). The necessary supple-
ments in the desired concentrations were added to the experimental solutions
directly from the appropriate stock solutions, dissolved in water, ethanol or
dimethylsulfoxide.AllchemicalswerepurchasedfromSigma-Aldrich(St.Louis,MO,
USA). In the course of the patch-clamp recording, drugs and solutions were applied
to the cells through the multiline microperfusion system with common outﬂow (Cell
MicroControls, Norfolk, VA, USA) placed in close proximity (B200mm) to the
studied cell. The experiments were carried out at room temperature.
Western blotting. LNCaP cells were treated with an ice-cold lysis buffer
containing 10mM Tris-HCl, pH 7.4, 150mM NaCl, 10mM MgCl, 1mM PMSF,
1% Nonidet P-40, and protease inhibitor cocktail from Sigma. The lysates were
centrifugedat15000 gand41Cfor20min,mixedwithasamplebuffercontaining
125mM Tris-HCl, pH 6.8, 4% SDS, 5% b-mercaptoethanol, 20% glycerol, and
0.01% bromophenol blue, and boiled for 5min at 951C. The total protein samples
were subjectedto 8–10%SDS-PAGE and transferred to a nitrocellulosemembrane
by semi-dry western blotting (Bio-Rad Laboratories, Hercules, CA, USA). The
membrane was blocked in a 5% milk TNT buffer (Tris-HCl, pH 7.4, 140mM NaCl,
and 0.05% Tween 20) overnight, and then probed using a speciﬁc rabbit polyclonal
anti-Orai1 antibody (1:200, ProScience, Poway, CA, USA) anti-mouse monoclonal
ant-STIM1antibody(1:250,BDBiosciences,MountainView,CA,USA)andanti-b-
actin (Lab Vision Co., Fremont, CA, USA, 1/1000) antibodies. The bands on the
membrane were visualized by enhanced chemiluminescence (Pierce
Biotechnologies Inc., Fremont, CA, USA). A densitometric analysis was
performed using a Bio-Rad image acquisition system (Bio-Rad Laboratories).
RT-PCR. RT-PCR experiments were performed as previously described.
31 DNA
ampliﬁcation conditions included the initial denaturation step of 7min at 951C, and
36 cycles of 30s at 951C, 30s at 601C, and 30s at 721C, and ﬁnally 7min at 721C.
Primers used are listed in Table 1.
siRNA transfection. LNCaP cells were transfected with 50nM of siRNA
against Orai1, STIM1, and AR (Dharmacon Inc., Fremont, CA, USA) using 6ml
Hyperfect transfection reagent (Qiagen Inc., Courtaboeuf, France), following the
manufacturer’s instructions (see Table 1 for the siRNA sequences).
Nucleofection. The transfection of LNCaP with different plasmids was
carried out using Nucleofector (Amaxa GmbH, Ko ¨ln, Germany) according to the
manufacturer’s instructions. In brief, 2mg of the plasmid was transfected into
2 million trypsinized cells, which were then plated onto six-well dishes, 35-mm
dishes or onto glass coverslips for 48h.
Immunocytochemistry. Cells grown on glass coverslips were washed once
with PBS and ﬁxed in 3.5% paraformaldehyde in PBS. Fluorescence analysis was
carried out using a Carl Zeiss LSM 510 connected to a Zeiss Axiovert 200M with
63 1.4numericalapertureoilimmersionlens atroomtemperature.Bothchannels
wereexcited,collectedseparately,andthenmergedtoexaminecolocalizationusing
Carl Zeiss LSM Image Examiner software (Le Pecq, France).
Apoptosis assay. The level of apoptosis was estimated from the number of
apoptotic nuclei revealed either by TUNEL assay (Roche Biochemicals, Burlington,
NC,USA)orbyHoechststaining.Thepercentageofapoptoticcellswasdetermined
bycountingat leastﬁverandomﬁeldsforeachconditiondoneintriplicateforeachn
(the detailed procedure has been described previously).
8
Quantitative real-time PCR. The quantitative real-time PCR of Orai1,
STIM1, and HPRT mRNA transcript was done using MESA GREEN qPCR
MasterMix Plus for SYBR Assay (Eurogentec, Angers, France) on the Biorad
CFX96 Real-Time PCR Detection System. The sequences of primers are indicated
in Table 1. The HPRT gene was used as an endogenous control to normalize
variations in the RNA extractions, the degree of RNA degradation, and variability in
RT efﬁciency. To quantify the results, we used the comparative threshold cycle
method described by Livak and Schmittgen.
32
Cloning of Orai1 and STIM1 and the site-directed
mutagenesis. All of the procedures used to clone Orai1 and STIM1 and to
create the two Orai1 mutants, the ‘selectivity mutant’ R91W and the ‘coiled-coil
mutant’ L273S, have been previously described in detail.
12
Data analysis. For each type of experiment, data were accumulated from at
least ﬁve measurements. Electrophysiological data were analyzed ofﬂine using
HEKA (HEKA Electronic) and Origin 7.0 (Microcal Software Inc., Northampton, MA,
USA) software. The results were expressed as mean±S.E.M., where appropriate.
A Student’s t-test was used for the statistical comparison of the differences, with
Po0.05 considered as signiﬁcant. In the graphs, (*) and (**) denote statistically
signiﬁcant differences of Po0.05 and Po0.01, respectively.
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